TJPC(SH:600488) Sou Hu Cai Jing·2026-01-29 19:43Summary of Key Points Core Viewpoint - Tianyao Pharmaceutical (600488) is facing regulatory scrutiny due to violations related to information disclosure and internal control issues, which may impact investor confidence and operational integrity [1][3]. Trading Information - As of January 29, 2026, Tianyao Pharmaceutical's stock closed at 4.2 yuan, down 1.64%, with a turnover rate of 1.15%, a trading volume of 125,400 shares, and a transaction value of 52.7973 million yuan [1]. Capital Flow - On January 29, 2026, the net outflow of main funds was 1.475 million yuan, accounting for 2.79% of the total transaction value; retail investors experienced a net outflow of 404,800 yuan, representing 0.77% of the total transaction value, while speculative funds saw a net inflow of 1.8798 million yuan, making up 3.56% of the total transaction value [1][3]. Regulatory Penalties - On January 28, 2026, Tianyao Pharmaceutical and several executives were ordered to rectify their actions by the Tianjin Securities Regulatory Bureau due to violations of securities laws and regulations, including failure to disclose significant events in a timely manner [1][3]. Company Announcements - On January 27, 2026, Tianyao Pharmaceutical received an administrative regulatory measure decision from the Tianjin Securities Regulatory Bureau, citing issues with non-compliant contracts for technology projects and failure to timely identify risks related to R&D project terminations, which led to delays in the recovery of advance payments [1][3].